Life Science Investing Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
Life Science Investing Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Life Science Investing Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 for the Treatment of PH-HFpEF
Life Science Investing Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Life Science Investing Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Life Science Investing Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
Life Science Investing Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
LaFleur Minerals Closes LIFE, Flow Thru and Final Hard Dollar Offering for $900,000 to Complete Total of $7,800,421 Funding to Restart Beacon Gold Mill Production Operations in Abitibi Greenstone Belt
Nextech3D.ai Closes Krafty Labs Acquisition Expanding into a Comprehensive End-to-End AI-Powered Live Events and Experiential Engagement Platform
RZOLV Technologies Successfully Completes Bulk-Scale Vat Leach Test at Operating Gold Mine, Advancing Commercial Validation of RZOLV Non-Cyanide Gold Extraction
